• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510600
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ossification (1428); Dysphagia/ Odynophagia (1815); Inflammation (1932); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Respiratory Distress (2045); Weakness (2145); Discharge (2225); Osteolysis (2377); Ambulation Difficulties (2544); Patient Problem/Medical Problem (2688); No Code Available (3191)
Event Type  Injury  
Event Description
It was reported that the patient underwent a lumbar interbody fusion using rhbmp-2/acs.The patient's post-operative period was marked by severe pain.Following the surgery the patient suffered from autonomic neuropathy, small fiber neuropathy, peripheral neuropathy, muscle atrophy and nerve damage, inflammatory reactions, chronic radiculitis, sterility, osteolysis (bone resorption), displacement or migration of the spacer cage, pseudoarthrosis, dysphagia, difficulty breathing, difficulty gripping and holding items, and chronic pain.The patient now suffers from bone overgrowth causing nerve compression, chronic pain and radiculitis, and emotional distress and mental anguish.
 
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Products from multiple manufacturers were implanted during the procedure.Although it is unknown if any of the devices contributed to the reported event, we are filing this mdr for notification purposes.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the patient underwent an alif/xilf fusion surgery at l4-5 using rhbmp2 and an interbody cage.The patient's post-operative period was marked by urinary complications, infections, odor/discharge, painful intercourse, and difficulty walking.
 
Event Description
It was reported that on (b)(6) 2007: the patient presented with degenerative disc disease to level l5-s1 and l4-5.Low back pain.Lower extremity sciatica.Lumbar spondylosis to level l4-5, l5-s1.The patient underwent the following procedures: anterior lumbar discectomy infusion/arthrodesis through a retroperitoneal extreme lateral or xlif procedure or approach at l4-5.Anterior instrumentation at l4-5.Inter-body spacer block or cage at l4-5.Posterior fusion, l4-5 with posterior non-segmental instrumentation, l4-5.Anterior lumbar discectomy and fusion second level, l5-s1 through a retroperitoneal trans-s1 approach.Anterior instrumentation at l5-s1.Inter-body cage at l5-s1.Bone grafting with bone morphogenic protein (bmp).The lordotic cage, 10x45 mm at l4-5.Four screws (6.5 mm), 240s and 245s at l4 and l5 pedicles with the appropriate rods.Bmp was used in the cages.The trans-s1 bolt or rod was used for fixation at l5-s1.It was a 40 mm bolt.Again, bmp was used along with the local auto-graft bone at the l4-5 level.Intra-operative neural monitoring by using surgeon driven monitoring.As per-op notes, "the l4-5 disk space was identified and annulotomy was performed.The disc was removed.The cage was prepared, packed with the bmp and then the trial was removed and the final cage was impacted into place.Excellent placement was confirmed with anterior-posterior and lateral c-arm.At s1, complete discectomy was performed utilizing the trans-s1 disc removal set.The disc space was packed with the local autogenous bone along with bmp (bone morphogenic protein) and some bone graft.".
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
huzefa mamoola
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key3659420
MDR Text Key4313299
Report Number1030489-2014-00721
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup,Followup
Report Date 06/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2009
Device Catalogue Number7510600
Device Lot NumberM110601AAA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received06/14/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/28/2006
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-